A hematologic support score for longitudinal measurement of blood and iron requirements in hereditary hemorrhagic telangiectasia and other chronic bleeding disorders

被引:8
作者
Al-Samkari, Hanny [1 ]
Naik, Rakhi P. [2 ]
Zakai, Neil A. [3 ]
机构
[1] Harvard Med Sch, Massachusetts Gen Hosp, Div Hematol, Boston, MA 02115 USA
[2] Johns Hopkins Univ, Div Hematol, Baltimore, MD USA
[3] Univ Vermont, Dept Med, Dept Pathol & Lab Med, Larner Coll Med, Burlington, VT USA
关键词
blood transfusion; clinical trials; hereditary hemorrhagic telangiectasia; HHT; intravenous iron; Osler-Weber-Rendu;
D O I
10.1002/rth2.12444
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1340 / 1342
页数:3
相关论文
共 8 条
  • [1] Systemic bevacizumab for the treatment of chronic bleeding in hereditary haemorrhagic telangiectasia
    Al-Samkari, H.
    Kritharis, A.
    Rodriguez-Lopez, J. M.
    Kuter, D. J.
    [J]. JOURNAL OF INTERNAL MEDICINE, 2019, 285 (02) : 223 - 231
  • [2] An international, multicenter study of intravenous bevacizumab for bleeding in hereditary hemorrhagic telangiectasia: the InHIBIT-Bleed study
    Al-Samkari, Hanny
    Kasthuri, Raj S.
    Parambil, Joseph G.
    Albitar, Hasan A.
    Almodallal, Yahya A.
    Vazquez, Carolina
    Serra, Marcelo M.
    Dupuis-Girod, Sophie
    Wilsen, Craig B.
    McWilliams, Justin P.
    Fountain, Evan H.
    Gossage, James R.
    Weiss, Clifford R.
    Latif, Muhammad A.
    Issachar, Assaf
    Mei-Zahav, Meir
    Meek, Mary E.
    Conrad, Miles
    Rodriguez-Lopez, Josanna
    Kuter, David J.
    Iyer, Vivek N.
    [J]. HAEMATOLOGICA, 2021, 106 (08) : 2161 - 2169
  • [3] Systemic bevacizumab for high-output cardiac failure in hereditary hemorrhagic telangiectasia: an international survey of HHT centers
    Al-Samkari, Hanny
    Albitar, Hasan A.
    Olitsky, Scott E.
    Clancy, Marianne S.
    Iyer, Vivek N.
    [J]. ORPHANET JOURNAL OF RARE DISEASES, 2019, 14 (01)
  • [4] ALSAMKARI H, 2020, HAEMOPHILIA 0908, DOI DOI 10.1111/HAE.14140
  • [5] Bernhart FW, 1943, J BIOL CHEM, V147, P19
  • [6] Elgailani IEH., 2016, ADV ANAL CHEM, V6, P35, DOI DOI 10.5923/J.AAC.20160602.01
  • [7] Prevalence and predictors of anemia in hereditary hemorrhagic telangiectasia
    Kasthuri, Raj S.
    Montifar, Megan
    Nelson, Jeffrey
    Kim, Helen
    Lawton, Michael T.
    Faughnan, Marie E.
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2017, 92 (10) : E591 - E593
  • [8] Hereditary hemorrhagic telangiectasia: diagnosis and management from the hematologist's perspective
    Kritharis, Athena
    Al-Samkari, Hanny
    Kuter, David J.
    [J]. HAEMATOLOGICA, 2018, 103 (09) : 1433 - 1443